This message contains images. If you don't see images, click here to view.
Advertise in this news brief.

Text Version   RSS   Subscribe   Unsubscribe   Archive   Media Kit          August 14, 2015

AUGS Home     Membership     Education     Professional Resources     Practice Management    


Submit a late breaking abstract for PFD Week 2015 by Sept. 1
AUGS accepts abstracts for oral, poster, and video presentations. Work submitted for presentation at this meeting may not have been previously published, and may not have been previously presented at another national Obstetrics and Gynecology (SGS, ACOG, AAGL) or Urology (SUFU, AUA) meeting. Abstracts that have been presented at non-OBGYN or Urology meetings will be accepted for poster presentation only and will not be eligible for prizes. The author must list where and when the research was presented at the bottom of the abstract when submitted. It is acceptable, however, for it to have been presented at an international meeting outside the United States.

Visit to access the abstract site.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Submit an abstract now for the PFD Week 2015 Fellows' Forum
The Fellows' Forum, part of Fellows' Day at PFD Week 2015, is an opportunity for OB/GYN and Urology Fellows from across the country to meet one another and present their scientific work in a fellows-only podium session.

To present at the Fellows-only podium session, which will be a non-competitive atmosphere, Fellows must submit a written abstract for presentation at this Forum. Abstracts may be different from, or duplicates of those submitted to PFD Week, the AUGS Annual Scientific Meeting, and will be accepted to the Fellows' Forum whether or not they were accepted for presentation the meeting. Abstract submissions will be accepted until September 11.

Submit your abstract today.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Register for AUGS' 36th Annual Meeting, PFD Week 2015!
Join AUGS in Seattle from Oct. 13-17 for the premier of PFD Week, an expansion of the successful AUGS Annual Scientific Meeting. With the traditional two and a half days of scientific presentations and an addition of one day of clinical and surgical workshops, PFD Week 2015 is the go-to meeting for healthcare professionals interested in or actively practicing Female Pelvic Medicine and Reconstructive Surgery.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


AUGS Weekly Poll
In order to increase the knowledge and understanding of the growing AUGS membership, AUGS created the AUGS Weekly Poll. This poll, circulated in FPMRS News, will help AUGS collect information from the membership on a variety of topics. The poll will also feature clinical questions to help members benchmark themselves with their peers. The weekly poll will allow AUGS to receive feedback that will be used by staff as well as volunteer leaders from AUGS committees and SIGs to make decisions that will benefit the membership.

Question: How often do you visit the AUGS website?


Click here to see the results of last week's poll.

Do you have an idea for a poll question? Email your question to to be reviewed by the AUGS Membership Committee.

Missed an issue of FPMRS News? Click here to visit the FPMRS News archive page.


ALLERGAN is continuing to research and develop new treatments for urogynecologists and urologists. In fact, that devotion is demonstrated by our considerable investment to address the continuum of care for patients with Overactive Bladder.


From bladder to systemic syndrome: Concept and treatment evolution of interstitial cystitis
International Journal of Women's Health via PubMed
Interstitial cystitis, presently known as bladder pain syndrome, has been recognized for over a century but is still far from being understood. Its etiology is unknown and the syndrome probably harbors different diseases. Autoimmune dysfunction, urothelial leakage, infection, central and peripheral nervous system dysfunction, genetic disease, childhood trauma/abuse, and subsequent stress response system dysregulation might be implicated. Management is slowly evolving from a solo act by the end-organ specialist to a team approach based on new typing and phenotyping of the disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Fixation of light weight polypropylene mesh with n-butyl-2-cyanocrylate in pelvic floor surgery: Experimental design approach in sheep for effectiveness evaluation
BioMed Research International via PubMed Central
Pelvic organ prolapse is a common occurrence that has become more prevalent in view of the aging population. It is not a life threating condition and death rate is almost nonexistent but it substantially affects the quality of life. The normal occurrence of pelvic organ support defects in women has still not been properly investigated. However, recent studies have described a POP prevalence of 30–50 percent diagnosticated by gynecologic examination in women between 45 and 85 years of age, with prevalence of symptomatology reported by the patient ranging from 4 to 12 percent.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Neuromodulation for OAB symptoms
Incontinence experts discuss the prevalence of refractory OAB and how Urgent® PC can help this undertreated population. To view the supplement:
Lantheus Proven Success
Discovering, developing and marketing innovative medical imaging agents provides a strong platform from which to bring forward new breakthrough tools for the diagnosis and management of disease.

Procedure for prolapse and hemorrhoids vs. traditional surgery for outlet obstructive constipation
World Journal of Gastroenterology
Constipation is the most common chronic digestive symptom of many causes. It is characterized by decreased defecation frequency, decreased amount of feces, dry feces, and difficulty in defecation. The incidence of constipation is associated with many factors including sex, age, dietary habit and occupation. Statistics show that the incidence of constipation is as high as 20 percent in the general population. In recent years, due to the continuous improvement of living standards, the incidence of constipation has been increasing, and thus has become one of the important factors that seriously affect human health.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Combined detrusor-trigone BTX-A injections for urinary incontinence secondary to neurogenic detrusor overactivity
Detrusor overactivity is characterized by spontaneous or provoked involuntary detrusor contractions during storage phase in urodynamic investigation. Neurogenic DO is DO caused by various neurogenic diseases such as brain tumors, dementia, multiple sclerosis, Parkinson's disease, stroke and spinal cord injury. NDO can cause a variety of long-term complications such as urinary incontinence, stones, hydronephrosis, recurrent urinary tract infection and VUR; the most dangerous being damage of renal function. These complications may markedly impact the quality of life of people with SCI, including limiting their behavior, causing social embarrassment and possibly threatening their life.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Postoperative ureteral obstruction after endoscopic treatment for vesicoureteral reflux
Korean Journal of Urology via PubMed Central
Vesicoureteral reflux is present in about 1 percent of healthy children and in 30 percent to 50 percent of children with symptomatic urinary tract infections. Treatments for VUR can be classified into four types: Observation, antibiotic prophylaxis, open surgery and endoscopic treatment. The endoscopic treatment of VUR was first introduced in 1981 by Matouschek with the use of polytetrafluoroethylene. Recently, endoscopic treatment of VUR has gained widespread popularity and has become an alternative to ureteral reimplantation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article

Overactive bladder successfully treated with duloxetine in a female adolescent
Clinical Psychopharmacology and Neuroscience
Overactive bladder is defined as urgency, usually with frequency and nocturia, and with or without urge incontinence. Duloxetine, an antidepressant that inhibits reuptake of serotonin and norepinephrine, is indicated for the treatment of stress urinary incontinence in Europe. In this paper, we present a case of a 17-year-old female patient with OAB and depressive symptoms who was successfully treated with duloxetine. This case suggests duloxetine can be an option for patient with OAB, and it also highlights the need for further studies of duloxetine's use in the treatment of OAB.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Taking an integrative approach to treating pelvic pain
Estimates of up to 30 million women and an unknown number of men suffer from chronic pelvic pain in the U.S. alone. There are many conditions that overlap in the pelvis and the entire body, so we need to look at the whole person and be able to "connect the dots" in pelvic pain management.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article


Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Caitlin McNeely, Senior Editor, 469.420.2692  
Contribute news

Inclusion of advertisements does not constitute AUGS endorsement of company products or services.

Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of the FPMRS News was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

Aug. 7, 2015
July 31, 2015
July 31, 2015 blast
July 24, 2015

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063